10-Jun-2026
Teleflex grants special RSU award to interim CEO
TipRanks (Tue, 9-Jun 6:18 PM ET)
Business Wire (Tue, 9-Jun 6:30 AM ET)
TipRanks (Mon, 8-Jun 5:36 AM ET)
Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering
Business Wire (Mon, 1-Jun 5:40 PM ET)
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032
Business Wire (Mon, 1-Jun 7:45 AM ET)
Business Wire (Thu, 21-May 6:30 AM ET)
Teleflex Announces Quarterly Dividend
Business Wire (Fri, 15-May 4:30 PM ET)
Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook
Business Wire (Thu, 7-May 6:30 AM ET)
Teleflex Appoints Jason Weidman as President and CEO
Business Wire (Thu, 30-Apr 6:30 AM ET)
Teleflex Announces First Quarter 2026 Earnings Conference Call Information
Business Wire (Thu, 23-Apr 6:30 AM ET)
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
Teleflex trades on the NYSE stock market under the symbol TFX.
As of June 10, 2026, TFX stock price declined to $132.15 with 500,946 million shares trading.
TFX has a beta of 1.08, meaning it tends to be more sensitive to market movements. TFX has a correlation of 0.11 to the broad based SPY ETF.
TFX has a market cap of $5.85 billion. This is considered a Mid Cap stock.
Last quarter Teleflex reported $548 million in Revenue and $1.39 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.17.
In the last 3 years, TFX traded as high as $262.97 and as low as $100.18.
The top ETF exchange traded funds that TFX belongs to (by Net Assets): IJR, VTI, VB, VBR, VXF.
TFX has underperformed the market in the last year with a return of +8.3%, while SPY returned +22.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in TFX shares. However, TFX has outperformed the market in the last 3 month and 2 week periods, returning +16.6% and +0.2%, while SPY returned +7.2% and -3.4%, respectively. This indicates TFX has been having a stronger performance recently.
TFX support price is $133.17 and resistance is $138.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFX shares will trade within this expected range on the day.